The impact of the Coronavirus disease 2019 on hospitalizations for coronary artery revascularization: results from California State Inpatient Database.
Journal
Coronary artery disease
ISSN: 1473-5830
Titre abrégé: Coron Artery Dis
Pays: England
ID NLM: 9011445
Informations de publication
Date de publication:
01 03 2023
01 03 2023
Historique:
entrez:
31
1
2023
pubmed:
1
2
2023
medline:
3
2
2023
Statut:
ppublish
Résumé
Coronavirus disease 2019 (COVID-19) outbreak has negatively impacted routine cardiovascular care. In this study, we assessed the impact of COVID-19 pandemic on percutaneous coronary artery intervention (PCI) and coronary artery bypass grafting (CABG) hospitalizations and outcomes using a large database. The current study was a retrospective analysis of California State Inpatient Database (SID) during March-December of 2019 and 2020. All adult hospitalizations for coronary artery revascularization were included for the analysis. ICD-10-CM diagnosis and procedure codes were used for identifying hospitalizations and procedures. The primary outcome was inhospital mortality, and secondary outcomes were hospital length of stay, stroke, acute kidney injury, and mechanical ventilation. Propensity score match analysis was done to compare adverse clinical outcomes. PCI hospitalizations (relative decrease, 15.0%, P for trend <0.001) and CABG hospitalizations (relative decrease, 16.4%, P for trend <0.001) decreased from 2019 to 2020, while viral pneumonia hospitalizations increased (relative increase, 1751.6%, P for trend <0.001). Monthly PCI and CABG hospitalization showed decreasing trends from January 2019 to December 2020. Propensity score match analysis showed that the odds of inhospital mortality (OR, 1.12; 95% CI, 1.01-1.24), acute kidney injury (OR, 1.12; 95% CI, 1.06-1.17), and ARDS (OR, 1.89; 95% CI, 1.18-3.01) were higher among patients who received PCI in 2020. Results of our study indicate that initiatives such as encouraging patients to receive treatments and controlling the spread of COVID-19 should be instituted to improve PCI and CABG hospitalizations.
Sections du résumé
BACKGROUND
Coronavirus disease 2019 (COVID-19) outbreak has negatively impacted routine cardiovascular care. In this study, we assessed the impact of COVID-19 pandemic on percutaneous coronary artery intervention (PCI) and coronary artery bypass grafting (CABG) hospitalizations and outcomes using a large database.
METHODS
The current study was a retrospective analysis of California State Inpatient Database (SID) during March-December of 2019 and 2020. All adult hospitalizations for coronary artery revascularization were included for the analysis. ICD-10-CM diagnosis and procedure codes were used for identifying hospitalizations and procedures. The primary outcome was inhospital mortality, and secondary outcomes were hospital length of stay, stroke, acute kidney injury, and mechanical ventilation. Propensity score match analysis was done to compare adverse clinical outcomes.
RESULTS
PCI hospitalizations (relative decrease, 15.0%, P for trend <0.001) and CABG hospitalizations (relative decrease, 16.4%, P for trend <0.001) decreased from 2019 to 2020, while viral pneumonia hospitalizations increased (relative increase, 1751.6%, P for trend <0.001). Monthly PCI and CABG hospitalization showed decreasing trends from January 2019 to December 2020. Propensity score match analysis showed that the odds of inhospital mortality (OR, 1.12; 95% CI, 1.01-1.24), acute kidney injury (OR, 1.12; 95% CI, 1.06-1.17), and ARDS (OR, 1.89; 95% CI, 1.18-3.01) were higher among patients who received PCI in 2020.
CONCLUSION
Results of our study indicate that initiatives such as encouraging patients to receive treatments and controlling the spread of COVID-19 should be instituted to improve PCI and CABG hospitalizations.
Identifiants
pubmed: 36720023
doi: 10.1097/MCA.0000000000001218
pii: 00019501-202303000-00009
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
146-153Informations de copyright
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.
Références
Lobo AS, Cantu SM, Sharkey SW, Grey EZ, Storey K, Witt D, et al. Revascularization in patients with spontaneous coronary artery dissection and ST-segment elevation myocardial infarction. J Am Coll Cardiol 2019; 74:1290–1300.
Gluckman TJ, Wilson MA, Chiu S-T, Penny BW, Chepuri VB, Waggoner JW, et al. Case rates, treatment approaches, and outcomes in acute myocardial infarction during the coronavirus disease 2019 pandemic. JAMA Cardiol 2020; 5:1419–1424.
Parcha V, Kalra R, Glenn AM, Davies JE, Kuranz S, Arora G, et al. Coronary artery bypass graft surgery outcomes in the United States: impact of the coronavirus disease 2019 (COVID-19) pandemic. JTCVS Open 2021; 6:132–143.
Solomon MD, McNulty EJ, Rana JS, Leong TK, Lee C, Sung S-H, et al. The Covid-19 pandemic and the incidence of acute myocardial infarction. N Engl J Med 2020; 383:691–693.
Yong CM, Spinelli KJ, Chiu ST, Jones B, Penny B, Gummidipundi S, et al. Cardiovascular procedural deferral and outcomes over COVID-19 pandemic phases: a multi-center study. Am Heart J 2021; 241:14–25.
Patel V, Jimenez E, Cornwell L, Tran T, Paniagua D, Denktas AE, et al. Cardiac surgery during the coronavirus disease 2019 pandemic: perioperative considerations and triage recommendations. J Am Heart Assoc 2020; 9:e017042.
Arora S, Matsushita K, Qamar A, Stacey RB, Caughey MC. Early versus late percutaneous revascularization in patients hospitalized with non ST-segment elevation myocardial infarction: the atherosclerosis risk in communities surveillance study. Catheter Cardiovasc Interv 2018; 91:253–259.
Sobolev BG, Fradet G, Hayden R, Kuramoto L, Levy AR, FitzGerald MJ. Delay in admission for elective coronary-artery bypass grafting is associated with increased in-hospital mortality. BMC Health Serv Res 2008; 8:1–7.
European Society of Cardiology. Fear of COVID-19 keeping more than half of heart attack patients away from hospitals. https://www.escardio.org/The-ESC/Press-Office/Press-releases/Fear-of-COVID-19-keeping-more-than-half-of-heart-attack-patients-away-from-hospitals . [Accessed 16 September 2022]
Agency for Healthcare Research and Quality. Overview of the State Inpatient Databases (SID). https://www.hcup-us.ahrq.gov/sidoverview.jsp . [Accessed 6 September 2022]
Erik von Elm M, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007; 147:573e5577.
National Cancer Institute. Joinpoint trend analysis software. https://surveillance.cancer.gov/joinpoint/ . [Accessed 6 August 2022]
The Department of Health and Human Services. Hospitals reported that the COVID-19 pandemic has significantly strained health care delivery. https://oig.hhs.gov/oei/reports/OEI-09-21-00140.pdf . [Accessed 9 September 2022]
Garcia S, Albaghdadi MS, Meraj PM, Schmidt C, Garberich R, Jaffer FA, et al. Reduction in ST-segment elevation cardiac catheterization laboratory activations in the United States during COVID-19 pandemic. J Am Coll Cardiol 2020; 75:2871–2872.
Mafham MM, Spata E, Goldacre R, Gair D, Curnow P, Bray M, et al. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England. Lancet 2020; 396:381–389.
Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA, Hand M, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 2004; 44:E1–E211.
Tam C-CF, Cheung K-S, Lam S, et al. Impact of coronavirus disease 2019 (COVID-19) outbreak on ST-segment–elevation myocardial infarction care in Hong Kong, China. Circ: Cardiovasc Qual Outcomes 2020; 13:e006631.
Tam CCF, Cheung KS, Lam S, et al. Impact of coronavirus disease 2019 (COVID-19) outbreak on outcome of myocardial infarction in Hong Kong, China. Catheter Cardiovasc Interv 2021; 97:E194–E197.
American College of Cardiology. Coronavirus and your heart. Cardiosmart. https://www.cardiosmart.org/docs/default-source/assets/infographic/coronavirus-and-your-heart-dont-ignore-heart-symptoms.pdf?sfvrsn=4faedad8_1 . [Accessed 8 July 2022]
American College of Cardiology. American College of Cardiology urges heart attack, stroke patients to seek medical help. https://www.acc.org/about-acc/press-releases/2020/04/14/10/17/american-college-of-cardiology-urges-heart-attack-stroke-patients-to-seek-medical-help . [Accessed 6 September 2022]
Omer SB, Benjamin RM, Brewer NT, Buttenheim AM, Callaghan T, Caplan A, et al. Promoting COVID-19 vaccine acceptance: recommendations from the Lancet commission on vaccine refusal, acceptance, and demand in the USA. Lancet 2021; 398:2186–2192.